| 000 | 05921namaa22004451i 4500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20251109132831.0 | ||
| 008 | 251109s2025 ua a|||frm||| 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC _dEG-GICUC _erda |
||
| 041 | 0 |
_aeng _beng _bara |
|
| 049 | _aDeposit | ||
| 082 | 0 | 4 | _a573 |
| 092 |
_a573 _221 |
||
| 097 | _aM.Sc | ||
| 099 | _aCai01.12.21.M.Sc.2025.Mo.P | ||
| 100 | 0 |
_aMoshera Gamal Sayed, _epreparation. |
|
| 245 | 1 | 4 |
_aThe possible antineoplastic activity of Allolobophora caliginosa coelomic fluid against Ehrlich ascites carcinoma in Swiss albino mice / _cby Moshera Gamal Sayed ; Supervisors Prof. Dr. Amel Mahmoud Soliman, Prof. Dr. Sohair Ramadan Fahmy, Dr. Shimaa Ahmed Sadek. |
| 246 | 1 | 5 | _aالنشاط المضاد للأورام المحتمل للسائل الجوفي للألولوبوفرا كاليجينوزا ضد سرطان إيرلش الإستسقائي في الفئران السويسرية البيضاء |
| 264 | 0 | _c2025. | |
| 300 |
_a257 pages : _billustrations ; _c25 cm. + _eCD. |
||
| 336 |
_atext _2rda content |
||
| 337 |
_aUnmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 502 | _aThesis (M.Sc)-Cairo University, 2025. | ||
| 504 | _aBibliography: pages 188-257. | ||
| 520 | 3 | _aAllolobophora caliginosa has been widely utilized in the pharmaceutical industry because it has many therapeutic properties that attributed to its coelomic fluid. Hence, the current study was intended to identify the bioactive constituents and the biological activities of Allolobophora caliginosa coelomic fluid (ACCF) and its the possible antitumor effect against Ehrlich ascites carcinoma (EAC) in female Swiss albino mice. The effectiveness of ACCF was compared with fluorouracil (Flu) as a standard chemotherapy drug. Various active phenolic and flavonoid constituents and a considerable amount of essential and non-essential amino acids were found in ACCF. The current study clarified that ACCF exhibited dose-dependent radical scavenging and potent anti-inflammatory activities. Furthermore, the proliferation of HepG-2 could be inhibited by ACCF with the IC50 value of 145.99 μg/ml. The present findings revealed that ACCF showed amazing peripherally and centrally analgesic and antipyretic potencies. ACCF has various secondary metabolites that were likely to act synergistically to produce the observed biological activities. Besides, oral administration of ACCF for 9 days caused a significant amelioration in all the hematological parameters relative to the untreated EAC group. Markedly, ACCF administration significantly enhanced hepatic function by the reduction in liver enzyme activities such as ALT, AST, GGT, and lactate as well as the increase in total protein and albumin content. As well as, ACCF treatment improved renal function as indicated by the reduction in serum creatinine, urea and uric acid. Concerning lipid metabolism, ACCF treatment caused a marked enhancement in lipid metabolism, as indicated by a significant decrease in serum total cholesterol and triglycerides levels. Moreover, ACCF treatment could hinder the hepatic and renal oxidative stress induced by EAC via a noticeable increase in both hepatic and renal GSH content and antioxidant enzyme activities (SOD, CAT, and GST) besides reduction in MDA and NO formation. Administration of ACCF repairs, to some extent, the abnormal architecture of hepatic tissue induced by EAC. Finally, ACCF could be used as a prospective anti-tumor and hepato-renal protective alternative remedy. | |
| 520 | 3 | _aتهدف الدراسة الحالية إلي تقييم الفعالية المضادة للأورام للسائل الجوفي للألولوبوفرا كاليجينوزا ضد سرطان إيرلش الإستسقائي من خلال التعرف علي المركبات البيولوجية النشطه له. و أوضحت الدراسة الحالية العديد من الأنشطة البيوليوجية المختلفة للسائل الجوفي للألولوبوفرا كاليجينوزا مثل النشاط المضادة للأكسدة, نشاطًا قويًا مضادًا للالتهابات, نشاطاً فعالاً ضد سرطان الكبد الوبائي-2. كما لدية القدرة علي التخفيف من حدة الألم و إنخفاض درجة حرارة الجسم. كما أوضحت الدراسة الحالية أن سرطان إيرلش الإستسقائي تسبب في أضرار غير المرغوب فيها لمعظم القياسات البيوكيميائية. كما وجد تغير باثولوجي في كبد الفئران المصابة بسرطان إيرلش الإستسقائي. بينما أدت المعالجة بالسائل الجوفي للألولوبوفرا كاليجينوزلمدة 9 أيام إلي تثبيط نشاط الخلايا السرطانيه . كما أدت إلي تحسن لمعظم القياسات البيوكيميائية و التركيب النسيجي للكبد إلي مستوي يقترب من التركيب الطبيعي. و هذا وجد علي التوافق مع نتائج الفلورويورسيل كدواء للسرطان. | |
| 530 | _aIssues also as CD. | ||
| 546 | _aText in English and abstract in Arabic & English. | ||
| 650 | 0 | _aAnimal physiology | |
| 650 | 0 | _aفيسولوجيا الحيوانات | |
| 653 | 0 |
_aAllolobophora caliginosa coelomic fluid _aEhrlich ascites carcinoma _aAntioxidant _aHepatorenal disorders |
|
| 700 | 0 |
_aAmel Mahmoud Soliman _ethesis advisor. |
|
| 700 | 0 |
_aSohair Ramadan Fahmy _ethesis advisor. |
|
| 700 | 0 |
_aShimaa Ahmed Sadek _ethesis advisor. |
|
| 900 |
_b01-01-2025 _cAmel Mahmoud Soliman _cSohair Ramadan Fahmy _cShimaa Ahmed Sadek _UCairo University _FFaculty of Science _DDepartment of Zoology |
||
| 905 | _aShimaa | ||
| 942 |
_2ddc _cTH _e21 _n0 |
||
| 999 | _c175663 | ||